Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress

Key Takeaway: Cerus Corporation will present new evidence and innovations related to the INTERCEPT Blood System at the 39th International ISBT Congress. The event will highlight the company's global experience in blood safety and pathogen reduction technologies. Details on specific findings or innovations to be showcased were not provided.